
Adult Immunization
Latest News

Why Guideline-Recommended uACR Screening Is Still Being Missed, With Payal Kohli, MD

Heart Failure Reframed: Calling Clinicians to Shift Focus to Prevention, With Muthiah Vaduganathan, MD, MPH

“Ghost” Physicians Haunt Medicaid, Drive Access Gaps in Care

ACP Calls for End to “Provider” Terminology in Clinical Practice

Oral Ribupatide Produces Up to 12% Weight Loss in Phase 2 Obesity Trial
Shorts










Latest Videos
Podcasts
Screening
All News

Booster-backed speed-of-processing brain training links to lower Alzheimer disease and dementia diagnoses, suggesting modest computer exercises may delay decline.

Three-year BE HEARD data show bimekizumab sustains HS lesion clearance, cuts draining tunnels, and improves severity and quality of life.

FDA insulin updates, new obesity drug data, vaccine hesitancy strategies, and depression screening insights are featured in this week’s episode.

FDA clears a dissolvable sildenafil oral film for erectile dysfunction, offering discreet, water-free dosing and strong phase 3 results ahead of 2026 launch.

Researchers found that 58% of infants with atopic dermatitis achieved a 75% improvement in EASI-75 at week 4 with once-daily roflumilast cream 0.05%.

Physician researcher Fendrick offers an expert perspective on why removing cost barriers matters, and why navigation and patient realities still determine whether CRC screening succeeds.

Dr Hatfield shares a case of a patient living in shared housing who was concerned about her housemates seeing her PrEP medication.

A new study reveals icotrokinra's comparable efficacy to existing therapies, offering hope for treatment-refractory patients facing resistance challenges.

The FDA delays approval of Anaphylm, a sublingual epinephrine film for anaphylaxis, citing administration and human factors study deficiencies.












































































































































